Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

The Lancet

Volumn 371, Issue 9621, 2008, Pages 1337-1342

  Papp, K ^a   Bissonnette, R ^b   Rosoph, L ^c   Wasel, N ^d   Lynde, CW ^e   Searles, G ^f   Shear, NH ^g   Huizinga, RB ^h   Maksymowych, WP ⁱ  

^a PROBITY MEDICAL RESEARCH   (Canada)

^b INNOVADERM RESEARCH   (Canada)

^c North Bay Dermatology Centre   (Canada)

^d Stratica Medical Canada   (Canada)

^e Lynderm Research Inc Canada   (Canada)

^f Western Canada Dermatology Institute   (Canada)

^g Sunnybrook Dermatology   (Canada)

^h Isotechnika Inc   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; ISA 247; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; BLOOD PRESSURE; BODY SURFACE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCORING SYSTEM; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 42049103402     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60593-0     Document Type: Article

References (17)

1. Ellis C., Fradin M., Messana J., et al. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 324 (1991) 277-284
2. Ho V., Griffiths C., Albrecht G., et al. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol 141 (1999) 283-291
3. Ho V., Griffiths C., Berth-Jones J., et al. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. J Am Acad Dermatol 44 (2001) 643-651
4. Koo J., and Lee J. Cyclosporine: what clinicians need to know. Dermatol Clin 13 (1995) 897-907
5. Markham T., Watson A., and Rogers S. Adverse effects with long-term cyclosporine for severe psoriasis. Clin Exp Dermatol 27 (2002) 111-114
6. Paul C., Ho V., McGeown C., et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120 (2003) 211-216
7. Zachariae H., Hansen H., Kragballe K., and Olsen S. Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens. J Am Acad Dermatol 26 (1992) 415-419
8. Reich K., Nestle F., Papp K., et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 366 (2005) 1367-1374
9. Papp K., Tyring S., Lahfa M., et al. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol 152 (2005) 1304-1312
10. Hankin C., Feldman S., Szczotka A., et al. A cost comparison of treatments of moderate to severe psoriasis. Drug Benefit Trends 17 (2005) 200-214
11. Abel M., Aspeslet L., Freitag D., et al. ISATX247: a novel calcineurin inhibitor. J Heart Lung Transplant 20 (2001) 161
12. Aspeslet L., Freitag D., Trepanier D., et al. ISA(TX)247: a novel calcineurin inhibitor. Transplant Proc 33 (2001) 1048-1051
13. Maksymowych W., Jhangri G., Aspeslet L., et al. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247. J Rheumatol 29 (2002) 1646-1652
14. Bissonnette R., Papp K., Poulin Y., et al. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis. J Am Acad Dermatol 54 (2006) 472-478
15. Fredriksson T., and Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157 (1978) 238-244
16. Levey A., Bosch J., Lewis J., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
17. Koo J. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group. Br J Dermatol 139 (1998) 88-95